Payment overview · 2025
General Payments
$4,170.96
61 reported records · 18 companies
Healthcare provider profile · identity verified
Michael Issac Nagib, MD
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · LAKELAND, FL · NPI 1508286329
Verified facts
What the public records show
CMS Open Payments records show Michael Issac Nagib, MD received $4,170.96 in general payments during 2025 across 61 reported records.
Surmodics, Inc. accounted for 48.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 38 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $2,022.64 | 48.5% | 3 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $506.72 | 12.2% | 11 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $465.24 | 11.2% | 8 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $267.63 | 6.4% | 10 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $219.05 | 5.2% | 7 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $162.11 | 3.9% | 3 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$124.69 | 3.0% | 2 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $106.37 | 2.5% | 5 | 2025 |
| Sirtex Medical Inc | Unresolved — no canonical attribution shown | $68.10 | 1.6% | 2 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $37.02 | 0.9% | 2 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $29.20 | 0.7% | 1 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $28.27 | 0.7% | 1 | 2025 |
| Contego Medical, Inc | Unresolved — no canonical attribution shown | $27.09 | 0.7% | 1 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $26.68 | 0.6% | 1 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $26.53 | 0.6% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $24.26 | 0.6% | 1 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $15.64 | 0.4% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $13.72 | 0.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $2,241.83 | 59 |
| Consulting Fee | $1,800.00 | 1 |
| Travel and Lodging | $129.13 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $2,022.64 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $2,022.64 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $2,022.64 | 3 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $339.16 | 8 | 2025 |
Source payment records
|
|||||
| OBSIDIO Normalized: obsidio |
Device | Boston Scientific Corporation | $275.34 | 2 | 2025 |
Source payment records
|
|||||
| Pounce LP Thrombectomy Normalized: pounce lp thrombectomy |
Device | Surmodics, Inc. | $195.63 | 1 | 2025 |
Source payment records
|
|||||
| Pounce XL Thrombectomy Normalized: pounce xl thrombectomy |
Device | Surmodics, Inc. | $195.63 | 1 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $162.11 | 3 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $136.43 | 4 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $135.47 | 5 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $135.47 | 5 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $117.88 | 1 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $106.37 | 5 | 2025 |
Source payment records
|
|||||
| SOLITAIRE X Normalized: solitaire x |
Device | Medtronic, Inc. | $97.75 | 1 | 2025 |
Source payment records
|
|||||
| General - Balloons Normalized: general balloons |
Device | Boston Scientific Corporation | $97.25 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $82.62 | 3 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $70.42 | 3 | 2025 |
Source payment records
|
|||||
| LAVA LES (Liquid Embolic System) Normalized: lava les liquid embolic system |
Device | Sirtex Medical Inc | $68.10 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $46.08 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $43.78 | 1 | 2025 |
Source payment records
|
|||||
| INTHRILL THROMBECTOMY CATHETER Normalized: inthrill thrombectomy catheter |
Device | Stryker Corporation | $41.02 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $37.02 | 2 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $36.08 | 2 | 2025 |
Source payment records
|
|||||
| SEISMIQ LITHOTRIP_PI Normalized: seismiq lithotrip pi |
Device | Boston Scientific Corporation | $32.11 | 1 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $28.27 | 1 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $27.01 | 1 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $27.01 | 1 | 2025 |
Source payment records
|
|||||
| IN.PACT ADMIRAL Normalized: in pact admiral |
Device | Medtronic, Inc. | $26.94 | 1 | 2025 |
Source payment records
|
|||||
| CEREPAK UNIFORM Normalized: cerepak uniform |
Device | DePuy Synthes Sales Inc. | $26.53 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $24.26 | 1 | 2025 |
Source payment records
|
|||||
| SpyGlass Discover Normalized: spyglass discover |
Device | Boston Scientific Corporation | $20.79 | 1 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $16.11 | 1 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $16.11 | 1 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $15.64 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $13.72 | 1 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Stent Graft Normalized: gore tag conformable thoracic stent graft |
Device | W. L. Gore & Associates, Inc. | $5.90 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $3.84 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $3.67 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $4,170.96 · 61 records | Surmodics, Inc. | ARTIX MT, AZUR CX DETACHABLE, CEREPAK UNIFORM, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, ELUVIA, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Stent Graft, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, General - Balloons, IN.PACT ADMIRAL, INTHRILL THROMBECTOMY CATHETER, Indigo System, LAVA LES (Liquid Embolic System), OBSIDIO, Penumbra System, Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce XL Thrombectomy, Prestige Coil System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, Ranger, RotarexS 6 F x 135 cm, SEISMIQ LITHOTRIP_PI, SOLITAIRE X, SYMPHONY CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, SpyGlass Discover, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, THORAFLEX HYBRID, TREO ABDOMINAL STENT-GRAFT SYSTEM, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error